Variation in the dopamine D2 receptor gene plays a key role in human pain and its modulation by transcranial magnetic stimulation

Pain

Volumn 155, Issue 10, 2014, Pages 2180-2187

  Jääskeläinen, Satu K ^a   Lindholm, Pauliina ^b   Valmunen, Tanja ^a   Pesonen, Ullamari ^c   Taiminen, Tero ^a   Virtanen, Arja ^c   Lamusuo, Salla ^b   Forssell, Heli ^a   Hagelberg, Nora ^a   Hietala, Jarmo ^a   Pertovaara, Antti ^d  

^a TURKU UNIVERSITY HOSPITAL   (Finland)

^b Department of Neurology   (Finland)

^c UNIVERSITY OF TURKU   (Finland)

^d UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Brain dopamine system; Dopamine D2 receptor; Neuropathic pain; Quantitative sensory testing; Single nucleotide polymorphism 957C>T; Transcranial magnetic stimulation

Indexed keywords

CATECHOL METHYLTRANSFERASE; DOPAMINE 2 RECEPTOR;

ADULT; ANALGESIA; ARTICLE; BRAIN CORTEX; CLINICAL ARTICLE; DOPAMINERGIC SYSTEM; FEMALE; GENETIC REGULATION; GENETIC VARIABILITY; GENOTYPE; HOMOZYGOTE; HUMAN; MALE; NEUROMODULATION; NEUROPATHIC PAIN; NEUROPHYSIOLOGY; NOCICEPTION; NOCICEPTIVE STIMULATION; NUCLEOTIDE SEQUENCE; PAIN SEVERITY; PREVALENCE; RECEPTOR GENE; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; THERMAL ANALYSIS; TRANSCRANIAL MAGNETIC STIMULATION; AGED; GENETICS; MIDDLE AGED; PAIN; PAIN MEASUREMENT; PAIN THRESHOLD; PATHOPHYSIOLOGY; PROCEDURES;

ADULT; AGED; ANALGESIA; CATECHOL O-METHYLTRANSFERASE; FEMALE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; PAIN; PAIN MANAGEMENT; PAIN MEASUREMENT; PAIN THRESHOLD; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, DOPAMINE D2; TRANSCRANIAL MAGNETIC STIMULATION;

EID: 84908112332     PISSN: 03043959     EISSN: 18726623     Source Type: Journal    
DOI: 10.1016/j.pain.2014.08.029     Document Type: Article

References (73)

1. E.K. Aasvang, B. Brandsborg, B. Christensen, T.S. Jensen, and H. Kehlet Neurophysiological characterization of postherniotomy pain PAIN® 137 2008 173 181
2. N. Altier, and J. Stewart The role of dopamine in the nucleus accumbens in analgesia Life Sci 65 1999 2269 2287
3. N. Andre-Obadia, R. Peyron, P. Mertens, F. Mauguiere, B. Laurent, and L. Garcia-Larrea Transcranial magnetic stimulation for pain control. Double-blind study of different frequencies against placebo, and correlation with motor cortex stimulation efficacy Clin Neurophysiol 117 2006 1536 1544
4. O.B. Ansah, H. Leite-Almeida, H. Wei, and A. Pertovaara Striatal dopamine D2 receptors attenuate neuropathic hypersensitivity in the rat Exp Neurol 205 2007 536 546
5. P. Armero, C. Muriel, J. Santos, F.J. Sànchez-Montero, R.E. Rodríguez, and R. González-Sarmiento COMT (Val158Met) polymorphism is not associated to neuropathic pain in a Spanish population Eur J Pain 9 2005 229 232
6. N. Attal, G. Cruccu, M. Haanpää, P. Hansson, T.S. Jensen, T. Nurmikko, C. Sampaio, S. Sindrup, and P. Wiffen EFNS guidelines on pharmacological treatment of neuropathic pain Eur J Neurol 13 2006 1153 1169
7. D. Borsook, J. Upadhyay, E.H. Chudler, and L. Becerra A key role of the basal ganglia in pain and analgesia - insights gained through human functional imaging Mol Pain 6 2010 27 44
8. E.H. Chudler, and W.K. Dong The role of the basal ganglia in nociception and pain PAIN® 60 1995 3 38
9. W.C. Clark Pain sensitivity and the report of pain: an introduction to sensory decision theory Anesthesiology 40 1974 272 287
10. G. Cruccu, P. Anand, N. Attal, L. Garcia-Larrea, M. Haanpää, E. Jorum, and J. Serra EFNS guidelines on neuropathic pain assessment Eur J Neurol 11 2004 153 162
11. D.C. de Andrade, A. Mhalla, F. Adam, M. Jacobsen Texeira, and D. Bouhassira Neuropharmacological basis of rTMS-induced analgesia: the role of endogenous opioids PAIN® 152 2011 320 326
12. L.R. Derogatis, R.S. Lipman, and L. Covi SCL-90: an outpatient psychiatric rating scale - preliminary report Psychopharmacol Bull 9 1973 13 28
13. L. Diatchenko, A.G. Nackley, G.D. Slade, K. Bhalang, I. Belfer, M.B. Max, D. Goldman, and W. Maixner Catechol-O-methyltransferase gene polymorphisms are associated with multiple pain-evoking stimuli PAIN® 125 2006 216 224
14. L. Diatchenko, G.D. Slade, A.G. Nackley, K. Bhalang, A. Sigurdsson, I. Belfer, D. Goldman, K. Xu, S.A. Shabalina, D. Shagin, M.B. Max, S.S. Makarov, and W. Maixner Genetic basis for individual variations in pain perception and the development of a chronic pain condition Hum Mol Gen 14 2005 135 143
15. J. Duan, M.S. Wainwright, J.M. Comeron, N. Saitou, A.R. Sanders, J. Gelernter, and P.V. Gejman Synonymous mutations in the human dopamine receptor D2 (DRD2) affect mRNA stability and synthesis of the receptor Hum Mol Genet 12 2003 205 216
16. R.H. Dworkin Pain insensitivity in schizophrenia: a neglected phenomenon and some implications Schizophr Bull 20 1994 235 237
17. R.H. Dworkin, M. Backonja, M.C. Rowbotham, R.R. Allen, C.R. Argoff, G.J. Bennett, M.C. Bushnell, J.T. Farrar, B.S. Galer, J.A. Haythornthwaite, D.J. Hewitt, J.D. Loeser, M.B. Max, M. Saltarelli, K.E. Schmader, C. Stein, D. Thompson, D.C. Turk, M.S. Wallace, L.R. Watkins, and S.M. Weinstein Advances in neuropathic pain: diagnosis, mechanisms, and treatment recommendations Arch Neurol 60 2003 1524 1534
18. M.B. First, R.L. Spitzer, M. Gibbon, and J.B.W. Williams Structured clinical interview for DSM-IV axis I disorders (SCID-I, 4/97 version) 1997 Biometrics Research Department, New York State Psychiatric Institute New York, NY
19. S.B. Floresco, A.R. West, B. Ash, H. Moore, and A.A. Grace Afferent modulation of dopamine neuron firing differently regulates tonic and phasic dopamine transmission Nat Neurosci 6 2003 968 973
20. H. Forssell, S. Jääskeläinen, O. Tenovuo, and S. Hinkka Sensory dysfunction burning mouth syndrome PAIN® 99 2002 41 47
21. H. Forssell, O. Tenovuo, P. Silvoniemi, and S.K. Jääskeläinen Differences and similarities between atypical facial pain and neuropathic trigeminal pain Neurology 69 2007 1451 1459
22. M. Haanpää, N. Attal, M. Backonja, R. Baron, M. Bennett, D. Bouhassira, G. Cruccu, P. Hansson, J.A. Haythornthwaite, G.D. Iannetti, T.S. Jensen, T. Kauppila, T.J. Nurmikko, A.S.C. Rice, M. Rowbotham, J. Serra, C. Sommer, B.H. Smith, and R.D. Treede NeuPSIG guidelines on neuropathic pain assessment PAIN® 152 2011 14 27
23. N. Hagelberg, H. Forssell, J.O. Rinne, H. Scheinin, T. Taiminen, S. Luutonen, K. Någren, and S. Jääskeläinen Striatal dopamine D1 and D2 receptors in burning mouth syndrome PAIN® 101 2003 149 154
24. N. Hagelberg, H. Forssell, S. Aalto, J.O. Rinne, H. Scheinin, T. Taiminen, K. Någren, O. Eskola, and S.K. Jääskeläinen Altered dopamine D2 receptor binding in atypical facial pain PAIN® 106 2003 43 48
25. N. Hagelberg, I.K. Martikainen, H. Mansikka, S. Hinkka, K. Någren, J. Hietala, H. Scheinin, and A. Pertovaara Dopamine D2 receptor binding in the human brain is associated with the response to painful stimulation and pain modulatory capacity PAIN® 99 2002 273 279
26. N. Hagelberg, S.K. Jääskeläinen, I.K. Martikainen, H. Mansikka, H. Forssell, H. Scheinin, J. Hietala, and A. Pertovaara Striatal dopamine D2 receptors in modulation of pain in humans: a review Eur J Pharmacol 500 2004 187 192
27. H. Hannula, S. Ylioja, A. Pertovaara, A. Korvenoja, J. Ruohonen, R.J. Ilmoniemi, and S. Carlson Somatotopic blocking of sensation with navigated transcranial magnetic stimulation of the primary somatosensory cortex Hum Brain Mapp 26 2005 100 109
28. A. Hirayama, Y. Saitoh, H. Kishima, T. Shimokawa, S. Oshino, M. Hirata, A. Kato, and T. Yoshimine Reduction of intractable deafferentation pain by navigation-guided repetitive transcranial magnetic stimulation of the primary motor cortex PAIN® 122 2006 22 27
29. M. Hirvonen, A. Laakso, K. Någren, J.O. Rinne, T. Pohjalainen, and J. Hietala C957T polymorphism of the dopamine D2 receptor (DRD2) gene affects striatal DRD2 availability in vivo Mol Psychiatry 9 2004 1060 1061 [erratum in: Mol Psychiatry 2005;10:889]
30. M.M. Hirvonen, A. Laakso, K. Någren, J.O. Rinne, T. Pohjalainen, and J. Hietala C957T polymorphism of dopamine D2 receptor gene affects striatal DRD2 in vivo availability by changing the receptor affinity Synapse 63 2009 907 912
31. M.M. Hirvonen, V. Lumme, J. Hirvonen, U. Pesonen, K. Någren, T. Vahlberg, H. Scheinin, and J. Hietala C957T polymorphism of the human dopamine D2 receptor gene predicts extrastriatal dopamine receptor availability in vivo Prog Neuropsychopharmacol Biol Psychiatry 33 2009 630 636
32. J.M. Hooley, and M.L. Delagado Pain insensitivity in the relatives of schizophrenia patients Schizophr Res 47 2001 265 273
33. 158Met polymorphisms are associated with treatment response in electroconvulsive therapy Neurosci Lett 448 2008 79 83
34. S.K. Jääskeläinen Traumatic nerve injury: diagnosis, recovery, and risk factors for neuropathic pain J. Castro-Lopes, Current topics in pain 2009 IASP Press Seattle 165 184
35. S.K. Jääskeläinen, J.O. Rinne, H. Forssell, O. Tenovuo, V. Kaasinen, P. Sonninen, and J. Bergman Role of the dopaminergic system in chronic pain - a fluorodopa-PET study PAIN® 90 2001 257 260
36. S.K. Jääskeläinen, T. Teerijoki-Oksa, K. Forssell, A. Virtanen, and H. Forssell Sensory regeneration following intraoperatively verified trigeminal nerve injury Neurology 62 2004 1951 1957
37. J.M. Jarcho, E.A. Mayer, Z.K. Jiang, N.A. Feier, and E.D. London Pain, affective symptoms, and cognitive deficits in patients with cerebral dopamine dysfunction PAIN® 153 2012 744 754
38. H. Kehlet, T.S. Jensen, and C. Woolf Persistent postsurgical pain: risk factors and prevention Lancet 367 2006 1618 1625
39. H. Kim, J.K. Neubert, A. San Miguel, K. Xu, R.K. Krishnaraju, M.J. Iadarola, D. Goldman, and R.A. Dionne Genetic influence on variability in human acute experimental pain sensitivity associated with gender, ethnicity and psychological temperament PAIN® 109 2004 488 496
40. H. Kim, H. Lee, J. Rowan, J. Brahim, and R.A. Dionne Genetic polymorphisms in monoamine neurotransmitter systems show only weak association with acute post-surgical pain in humans Mol Pain 2 2006 24
41. P. Klepstad, O. Dale, F. Skorpen, P.C. Borchgrevink, and S. Kaasa Genetic variability and clinical efficacy of morphine Acta Anaesthesiol Scand 49 2005 902 908
42. B.R. Lawford, R.McD. Young, C.D. Swagell, M. Barnes, S.C. Burton, W.K. Ward, K.R. Heslop, S. Shadforth, A. van Daal, and C.P. Morris The C/C genotype of the C957T polymorphism of the dopamine D2 receptor is associated with schizophrenia Schizophr Res 73 2005 31 37
43. J.P. Lefaucheur, X. Drouot, Y. Keravel, and J.P. Nguyen Pain relief induced by repetitive transcranial magnetic stimulation of precentral cortex Neuroreport 12 2001 2963 2965
44. Q.S. Liu, J.T. Qiao, and N. Dafny D2 dopamine receptor involvement in spinal dopamine-produced antinociception Life Sci 51 1992 1485 1492
45. J. Lötsch, and G. Geisslinger Current evidence for a genetic modulation of the response to analgesics PAIN® 121 2006 1 5
46. J. Maarrawi, R. Peyron, P. Mertens, N. Costes, M. Magnin, M. Sindou, B. Laurent, and L. Garcia-Larrea Motor cortex stimulation for pain control induces changes in the endogenous opioid system Neurology 69 2007 827 834
47. J.E. Magnusson, and K. Fisher The involvement of dopamine in nociception: the role of D1 and D2 receptors in the dorsolateral striatum Brain Res 855 2000 260 266
48. C. Maier, R. Baron, T.R. Tölle, A. Binder, N. Birbaumer, F. Birklein, J. Giertmühlen, H. Flor, C. Geber, V. Huge, E.K. Krumova, G.B. Lanwhermeyer, W. Magerl, C. Maihöfner, H. Richter, R. Rolke, A. Scherens, A. Schwarz, C. Sommer, V. Tronnier, N. Üçeyler, M. Valet, G. Wasner, and R.-D. Treede Quantitative sensory testing in the German Research Network on Neuropathic Pain (DFNS): somatosensory abnormalities in 1236 patients with different neuropathic pain syndromes PAIN® 150 2010 439 450
49. I.K. Martikainen, N. Hagelberg, H. Mansikka, J. Hietala, K. Någren, H. Scheinin, and A. Pertovaara Association of striatal dopamine D2/D3 receptor binding potential with pain but not tactile sensitivity or placebo analgesia Neurosci Lett 376 2005 149 153
50. J.S. Mogil The genetic mediation of individual differences in sensitivity to pain and its inhibition Proc Natl Acad Sci U S A 96 1999 7744 7751
51. J.S. Mogil Are we getting anywhere with human pain genetics? PAIN® 146 2009 231 232
52. M. Monakhov, V. Golimbet, L. Abramova, V. Kaleda, and V. Karpov Association study of three polymorphisms in the dopamine D2 receptor gene and schizophrenia in the Russian population Schizophr Res 100 2008 302 307
53. J.P. Nguyen, J.P. Lefaucheur, P. Decq, T. Uchiyama, Carpentier, D. Fontaine, P. Brugieres, B. Pollin, A. Feve, S. Rostaing, P. Cesaro, and Y. Keravel Chronic motor cortex stimulation in the treatment of central and neuropathic pain. Correlations between clinical, electrophysiological and anatomical data PAIN® 82 1999 245 251
54. C. Nuti, R. Peyron, L. Garcia-Larrea, J. Brunon, B. Laurent, M. Sindou, and P. Mertens Motor cortex stimulation for refractory neuropathic pain: four year outcome and predictors of efficacy PAIN® 118 2005 43 52
55. A. Pertovaara, I.K. Martikainen, N. Hagelberg, H. Mansikka, K. Någren, J. Hietala, and H. Scheinin Striatal dopamine D2/D3 receptor availability correlates with individual response characteristics to pain Eur J Neurosci 20 2004 1587 1592
56. R. Peyron, B. Laurent, and L. García-Larrea Functional imaging of brain responses to pain. A review and meta-analysis Neurophysiol Clin 30 2000 263 288
57. S. Potvin, and S. Marchand Hypoalgesia in schizophrenia is independent of antipsychotic drugs: a systematic quantitative review of experimental studies PAIN® 138 2008 70 78
58. J.R. Ross, D. Rutter, K. Welsh, S.P. Joel, K. Goller, A.U. Wells, R. Du Bois, and J. Riley Clinical response to morphine in cancer patients and genetic variation in candidate genes Pharmacogenomics J 5 2005 324 336
59. N.E. Saade, S.F. Atweh, N.B. Bahuth, and S.J. Jabbur Augmentation of nociceptive reflexes and chronic deafferentation pain by chemical lesions of either dopaminergic terminals or midbrain dopaminergic neurons Brain Res 14 1997 1 12
60. J.I. Sage Pain in Parkinson's disease Curr Treat Options Neurol 6 2004 191 200
61. D.J. Scott, M.M. Heitzeg, R.A. Koeppe, C.S. Stohler, and J.K. Zubieta Variations in the human pain stress experience mediated by ventral and dorsal basal ganglia dopamine activity J Neurosci 26 2006 10789 10795
62. U.M. Stamer, L. Zhang, and F. Stüber Impact of genetic variants on pain and analgesia Eur J Pain Suppl 2 2008 18 24
63. A.P. Strafella, T. Paus, M. Fraraccio, and A. Dagher Striatal dopamine release induced by repetitive transcranial magnetic stimulation of the human motor cortex Brain 126 2003 2609 2615
64. T. Taiminen, L. Kuusalo, L. Lehtinen, H. Forssell, N. Hagelberg, O. Tenovuo, S. Luutonen, A. Pertovaara, and S. Jääskeläinen Psychiatric (axis I) and personality (axis II) disorders in patients with burning mouth syndrome or atypical facial pain Scand J Pain 2 2011 155 160
65. R. Takeda, T. Ikeda, F. Tsuda, H. Abe, H. Hashiguchi, Y. Ishida, and T. Nishimori Unilateral lesions of mesostriatal dopaminergic pathway alters the withdrawal response of the rat hindpaw to mechanical stimulation Neurosci Res 52 2005 31 36
66. B.K. Taylor, C. Joshi, and H. Uppal Stimulation of dopamine D2 receptors in the nucleus accumbens inhibits inflammatory pain Brain Res 987 2003 135 143
67. T. Tsubokawa, Y. Katayama, T. Yamamoto, T. Hirayama, and S. Koyama Chronic motor cortex stimulation for the treatment of central pain Acta Neurochir Suppl (Wien) 52 1991 137 139
68. T. Valmunen, A. Pertovaara, T. Taiminen, A. Virtanen, R. Parkkola, and S.K. Jääskeläinen Modulation of facial sensitivity by navigated rTMS in healthy subjects PAIN® 142 2009 149 158
69. H. Viisanen, O. Bonsu Ansah, and A. Pertovaara The role of the dopamine D2 receptor in descending control of pain induced by motor cortex stimulation in the neuropathic rat Brain Res Bull 89 2012 133 143
70. J.M. Woo, K.S. Yoon, and B.H. Yu Catechol O-methyltransferase genetic polymorphism in panic disorder Am J Psychiatry 159 2002 1785 1787
71. P.B. Wood Role of central dopamine in pain and analgesia Expert Rev Neurother 8 2008 781 797
72. L. Yavich, M.M. Forsberg, M. Karayiorgou, J.A. Gogos, and P.T. Männistö Site-specific role of catechol-O-methyltransferase in dopamine overflow within prefrontal cortex and dorsal striatum J Neurosci 27 2007 10196 10209
73. 158met genotype affects mu-opioid neurotransmitter responses to a pain stressor Science 299 2003 1240 1243